Stomach Cancer Trial, Recruiting NCT07400354 Sponsor: Fudan University Condition: Stomach Cancer
Back to Stomach Cancer

Stomach Cancer Trial, Recruiting

NCT07400354
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Adults aged 18 or older, any gender
  • People whose general health and ability to carry out daily activities falls within an acceptable range (scored 0–2 on a standard oncology scale), with a life expectancy of more than 3 months
  • People who have been diagnosed with stomach cancer that has spread to other parts of the body or to nearby tissues, confirmed by a laboratory test of cells or tissue
  • People whose recent blood and organ function test results (taken within 7 days before screening) meet specific minimum levels for white blood cells, platelets, haemoglobin, liver enzymes, protein, and kidney function (confirm exact values with the trial site)
  • People who have at least one measurable area of cancer that can be tracked on scans, as assessed using standard medical criteria
  • People who have not yet received chemotherapy for advanced disease, and who are planned to receive a first course of treatment combining immunotherapy (one of several approved medicines, chosen by the treating doctor) with chemotherapy (one of several approved combinations, chosen by the treating doctor)
  • People (or their legal representative or guardian) who are willing to sign a consent form confirming they understand the study and agree to take part

Who may not be able to join:

  • Women who are pregnant or breastfeeding, or women of childbearing age who have not used adequate contraception
  • People who have had another type of cancer in the past 5 years, except for certain previously cured skin cancers or cervical pre-cancers
  • People who have a brain tumour or cancer that has spread to the brain and is not currently under control, or who have significant pressure in the skull or neurological or psychiatric symptoms
  • People with serious or uncontrolled heart conditions — including heart attack, heart failure, unstable chest pain, significant fluid around the heart, or unstable heart rhythm — occurring within the 6 months before joining
  • People with serious neurological or psychiatric conditions such as dementia or epilepsy
  • People with severe or uncontrolled infections, or serious blood clotting problems, or a clear tendency to bleed
  • People with significant damage to major organs
  • People with a build-up of fluid around the lungs or in the abdomen that is causing breathing difficulty rated at a certain level of severity, and that requires direct local treatment
  • People who have been taking probiotics or antibiotics on a long-term basis
  • People whom the trial investigator considers unsuitable for the trial for any other reason

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 26 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
14 March 2024
Est. completion
14 March 2027

Where this trial is recruiting

🇨🇳 China

Primary endpoints

The gut microbiota predicts progression-free survival (PFS)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov